In the early phase of HBV-related LC patients, Sun et al. have observed an increase in population of Th17 cell and activation of hepatic stellate cell secreting pro-inflammatory cytokines (IL-17, TGF-β and IL-22) in LC patients. This evidence concerns the gene IL22 and laryngotracheoesophageal cleft.